Personal information

Other IDs

Scopus Author ID: 57201476517

Activities

Collapse all

Employment (1)

Northwestern Memorial Hospital: Chicago, IL, US

2022-07-01 to present | Critical Care Pharmacist (Pharmacy)
Employment
Source: Self-asserted source
Kendall Mores

Education and qualifications (2)

Purdue University West Lafayette: West Lafayette, Indiana, US

2014-08 to 2020-04 | B.S. Pharmaceutical Sciences
Education
Source: Self-asserted source
Kendall Mores

Purdue University: West Lafayette, IN, US

2020 | Doctor of Pharmacy
Education
Source: Self-asserted source
Kendall Mores

Works (9)

Identification of a novel delta opioid receptor agonist chemotype with potential negative allosteric modulator capabilities

Molecules
2021 | Journal article
DOI: 10.3390/molecules26237236
EID:

2-s2.0-85120166394

Part of ISSN: 14203049
Contributors: Meqbil, Y.J.; Su, H.; Cassell, R.J.; Mores, K.L.; Gutridge, A.M.; Cummins, B.R.; Chen, L.; van Rijn, R.M.
Source: Self-asserted source
Kendall Mores via Scopus - Elsevier

Modulating β-arrestin 2 recruitment at the δ- and μ-opioid receptors using peptidomimetic ligands

RSC Medicinal Chemistry
2021 | Journal article
DOI: 10.1039/D1MD00025J
Contributors: Krishna K. Sharma; Robert J. Cassell; Yazan J. Meqbil; Hongyu Su; Arryn T. Blaine; Benjamin R. Cummins; Kendall L. Mores; David K. Johnson; Richard M. van Rijn; Ryan A. Altman
Source: check_circle
Crossref
grade
Preferred source (of 2)‎

G protein-biased kratom-alkaloids and synthetic carfentanil-amide opioids as potential treatments for alcohol use disorder

British Journal of Pharmacology
2020 | Journal article
DOI: 10.1111/bph.14913
EID:

2-s2.0-85078671641

Part of ISSN: 14765381 00071188
Contributors: Gutridge, A.M.; Robins, M.T.; Cassell, R.J.; Uprety, R.; Mores, K.L.; Ko, M.J.; Pasternak, G.W.; Majumdar, S.; van Rijn, R.M.
Source: Self-asserted source
Kendall Mores via Scopus - Elsevier

Modulating β Arrestin-2 Recruitment at the δ- and μ-Opioid Receptors

2020-07-23 | Other
DOI: 10.26434/chemrxiv.12685928
Contributors: Krishna Sharma; Robert Cassell; HongYu Su; Arryn Blaine; Benjamin Cummins; Kendall Mores; David Johnson; Richard van Rijn; Ryan Altman
Source: check_circle
Crossref

A review of the therapeutic potential of recently developed G protein-biased kappa agonists

Frontiers in Pharmacology
2019 | Journal article
DOI: 10.3389/fphar.2019.00407
EID:

2-s2.0-85068425194
Contributors: Mores, K.L.; Cummins, B.R.; Cassell, R.J.; Van Rijn, R.M.
Source: Self-asserted source
Kendall Mores via Scopus - Elsevier

Arrestin recruitment and signaling by G protein-coupled receptor heteromers

Neuropharmacology
2019 | Journal article
DOI: 10.1016/j.neuropharm.2018.11.010
EID:

2-s2.0-85067608430
Contributors: Mores, K.L.; Cassell, R.J.; van Rijn, R.M.
Source: Self-asserted source
Kendall Mores via Scopus - Elsevier

Rubiscolins are naturally occurring G protein-biased delta opioid receptor peptides

European Neuropsychopharmacology
2019 | Journal article
DOI: 10.1016/j.euroneuro.2018.12.013
EID:

2-s2.0-85058943115
Contributors: Cassell, R.J.; Mores, K.L.; Zerfas, B.L.; Mahmoud, A.H.; Lill, M.A.; Trader, D.J.; van Rijn, R.M.
Source: Self-asserted source
Kendall Mores via Scopus - Elsevier

The meta-position of Phe<sup>4</sup> in leu-enkephalin regulates potency, selectivity, functional activity, and signaling bias at the delta and mu opioid receptors

Molecules
2019 | Journal article
DOI: 10.3390/molecules24244542
EID:

2-s2.0-85076711644

Part of ISSN: 14203049
Contributors: Cassell, R.J.; Sharma, K.K.; Su, H.; Cummins, B.R.; Cui, H.; Mores, K.L.; Blaine, A.T.; Altman, R.A.; van Rijn, R.M.
Source: Self-asserted source
Kendall Mores via Scopus - Elsevier

Critical role for G<inf>i/o</inf>-protein activity in the dorsal striatum in the reduction of voluntary alcohol intake in C57Bl/6 mice

Frontiers in Psychiatry
2018 | Journal article
DOI: 10.3389/fpsyt.2018.00112
EID:

2-s2.0-85045055749
Contributors: Robins, M.T.; Chiang, T.; Mores, K.L.; Alongkronrusmee, D.; van Rijn, R.M.
Source: Self-asserted source
Kendall Mores via Scopus - Elsevier
How many people are using ORCID?